CLB vs NOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CLB

37.0
AI Score
VS
NOV Wins

NOV

44.3
AI Score

Investment Advisor Scores

CLB

37score
Recommendation
SELL

NOV

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLB NOV Winner
Revenue 246.41M 2.05B NOV
Net Income 5.17M 19.00M NOV
Net Margin 2.1% 0.9% CLB
Operating Income 11.04M 47.00M NOV
ROE 1.9% 0.3% CLB
ROA 0.9% 0.2% CLB
Total Assets 586.78M 11.14B NOV
Cash 22.73M 1.34B NOV
Debt/Equity 0.43 0.28 NOV
Current Ratio 2.12 2.47 NOV
Free Cash Flow 3.64M -91.00M CLB

Relative Price Performance (Last 90 Days)

CLB 1M: -7.5% · 3M: -24.7% NOV 1M: +7.7% · 3M: -2.3%

Current Technical Phase

CLB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 41

RSI (14): 40.6 · Price: $10.60

NOV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 48

RSI (14): 48.3 · Price: $19.41

Fundamentals Snapshot

Metric CLB NOV
Market Cap
Forward P/E 15.8 15.3
Trailing P/E 16.2 77.2
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS 0.64 0.25
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, NOV is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.